BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3875968)

  • 1. Problems in the detection of complement-fixing immune complexes.
    Rødahl E
    Acta Pathol Microbiol Immunol Scand C; 1985 Jun; 93(3):125-30. PubMed ID: 3875968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of anti-F (ab')2 antibodies (pepsin agglutinators) with immune complexes as determined by enzyme-linked immunosorbent assays.
    Davey MP; Korngold L
    Int Arch Allergy Appl Immunol; 1982; 67(3):278-83. PubMed ID: 6977496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of circulating immune complexes with polyethylene glycol precipitation F(ab')2 anti-C3 ELISA.
    Xu RJ; Gu YA
    J Immunol Methods; 1990 Dec; 135(1-2):225-31. PubMed ID: 2273258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of circulating immune complexes by chicken anti-human C3 and anti-human C1q microELISA.
    Larsson A; Jonsson L; Sjöquist J
    J Immunol Methods; 1988 Oct; 113(1):93-9. PubMed ID: 3262687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-F(ab')2 antibodies that interfere with interpretation of the anti-C3 assay for immune complexes in children with rheumatic diseases.
    Olds LC; Miller JJ
    Arthritis Rheum; 1984 Mar; 27(3):330-6. PubMed ID: 6704194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The absence of circulating immune complexes in patients with ankylosing spondylitis.
    Maksymowych W; Dasgupta MK; Rothwell RS; Dossetor JB; Russell AS
    Rheumatol Int; 1981; 1(3):107-9. PubMed ID: 6981182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The measurement of IgG class circulating immune complexes in liver diseases using F(ab')2 anti C3 ELISA].
    Muratsugu M; Makino M; Kohda H; Sekiya C
    Rinsho Byori; 1987 Dec; 35(12):1385-91. PubMed ID: 3502152
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of solid phase Clq and horseradish peroxidase-conjugated goat anti-IgG for the detection of immune complexes in human serum.
    Wehler C; Andrews JM; Bing DH
    Mol Immunol; 1981 Mar; 18(3):157-62. PubMed ID: 6973690
    [No Abstract]   [Full Text] [Related]  

  • 9. Separation and characterization of complement-fixing immune complexes in juvenile rheumatoid arthritis patients.
    Moore TL; Dorner RW
    Rheumatol Int; 1986; 6(2):49-52. PubMed ID: 3532285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating antigen-antibody complexes in onchocerciasis.
    Steward MW; Sisley B; Mackenzie CD; El Sheikh H
    Clin Exp Immunol; 1982 Apr; 48(1):17-24. PubMed ID: 6979445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IgG detected in the C1q solid-phase immune-complex assay is not always of immune-complex nature.
    Hack CE; Belmer AJ
    Clin Immunol Immunopathol; 1986 Jan; 38(1):120-8. PubMed ID: 3484437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of circulating immune complex levels by ELISA using F(ab')2 anti-C3 antibody].
    Muratsugu M; Makino M
    Rinsho Byori; 1986 Oct; Spec No 69():53-9. PubMed ID: 3806992
    [No Abstract]   [Full Text] [Related]  

  • 13. Modified anti-C3 immune complex assay which avoids interference by anti-F(ab')2 antibodies.
    Fukuda K; Seino J; Kinoshita Y; Sudo K; Horigome I; Furuyama T; Yoshinaga K
    Tohoku J Exp Med; 1985 Jul; 146(3):337-47. PubMed ID: 3931296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Vanes LA
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clq binding activity of monomeric IgG].
    Uwatoko S; Aotsuka S; Okawa M; Yokohari R; Aizawa C; Suzuki K
    Arerugi; 1982 Oct; 31(10):1022-8. PubMed ID: 6984822
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement-activating rheumatoid-factor-containing complexes in patients with rheumatoid vasculitis.
    Elson CJ; Scott DG; Blake DR; Bacon PA; Holt PD
    Ann Rheum Dis; 1983 Apr; 42(2):147-50. PubMed ID: 6601932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure to find C1q-binding material and anti-IgG antibodies in ankylosing spondylitis.
    Duquesnoy B; Santoro F; Wattre P; Delcambre B
    Ann Rheum Dis; 1980 Oct; 39(5):449-52. PubMed ID: 6969066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the recommended use of anti-Clq for reducing non-specific reactions in solid-phase C1q assays for circulating immune complexes.
    Wainer EM; Schepers G; Schweizer K; Pusztai-Markos Z
    J Immunol Methods; 1984 Jan; 66(1):193-5. PubMed ID: 6363550
    [No Abstract]   [Full Text] [Related]  

  • 20. Presence of immune complex-like material in sera of patients with paraproteinaemia.
    Klein F; Lafeber GJ; Jongepier-Geerdes YE; Cats A; Kauffmann RH; Michiels JJ
    J Clin Pathol; 1981 Sep; 34(9):1036-9. PubMed ID: 7276217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.